Acyclovir Tablets — Class II drug recall D-0544-2018
Terminated recall by Apace KY LLC, reported 2018-03-07, distributed nationwide. Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets
| Recall number | D-0544-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apace KY LLC, Fountain Run, KY, United States |
| Recall initiated | 2018-02-09 |
| Classified | 2018-02-23 |
| Reported by FDA | 2018-03-07 |
| Terminated | 2019-09-10 |
| Distributed | Nationwide (US) |
| Quantity | 630 cartons |
| Reason classes | labeling |
| NDC | 50268-0061, 50268-0061-11, 50268-0061-15, 50268-0062, 50268-0062-11, 50268-0062-15 |
| Lot numbers | 19900 |
| Expiration dates | 2019-05 |
Product
Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478
Reason for recall
Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0544-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.